Ys Biopharma Co. Ltd (YS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | YS | AZN | AMGN | GILD | BMY |
| Company | Ys Biopharma Co. Ltd | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.9000 | 206.60 | 372.01 | 150.58 | 60.62 |
| High | 1.1000 | 207.69 | 377.00 | 153.26 | 60.93 |
| Low | 0.9000 | 204.05 | 371.39 | 150.09 | 59.65 |
| Latest | 1.0200 | 204.20 | 374.75 | 151.40 | 60.66 |
| Change | +0.1129 | -2.25 | -0.75 | +0.28 | +0.36 |
| % Change | +12.45% | -1.09% | -0.20% | +0.19% | +0.60% |
| Volume | 107,200 | 1,592,600 | 2,911,700 | 6,986,900 | 9,598,800 |
| 20-Day Average Volume | 81,165 | 2,907,065 | 3,021,635 | 8,419,010 | 13,081,560 |
| Previous Close | 0.9071 | 206.45 | 375.50 | 151.12 | 60.30 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8888 | 194.51 | 361.01 | 147.11 | 58.15 |
| 20-Day Raw Stochastic | 79.80% | 71.47% | 77.96% | 77.60% | 82.27% |
| 20-Day Relative Strength | 60.44 | 61.52 | 62.17 | 63.79 | 64.20 |
| Weighted Alpha | -21.89 | +46.18 | +32.38 | +48.00 | +20.88 |
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 48% Buy | 64% Buy | 88% Buy | 96% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.31% since 05/17/24 | -0.16% since 02/12/26 | +2.33% since 02/12/26 | -0.27% since 02/12/26 | +1.34% since 02/12/26 |
| Low | 0.8810 on 05/22/24 | 204.05 on 02/20/26 | 361.71 on 02/13/26 | 150.09 on 02/20/26 | 59.23 on 02/19/26 |
| High | 1.1000 on 05/24/24 | 212.71 on 02/18/26 | 380.58 on 02/18/26 | 156.95 on 02/13/26 | 61.30 on 02/17/26 |
| 1-Month | |||||
| %Chg | +25.93% since 04/24/24 | +13.52% since 01/20/26 | +13.22% since 01/20/26 | +21.96% since 01/20/26 | +11.88% since 01/20/26 |
| Low | 0.7040 on 04/30/24 | 178.08 on 01/21/26 | 329.32 on 01/21/26 | 122.68 on 01/21/26 | 53.54 on 01/21/26 |
| High | 1.1000 on 05/24/24 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +158.29% since 02/23/24 | +15.13% since 11/20/25 | +11.51% since 11/20/25 | +21.13% since 11/20/25 | +32.04% since 11/20/25 |
| Low | 0.3800 on 03/01/24 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.52 on 11/21/25 |
| High | 1.1000 on 05/24/24 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +63.51% since 11/24/23 | +26.80% since 08/20/25 | +26.41% since 08/20/25 | +27.52% since 08/20/25 | +25.69% since 08/20/25 |
| Low | 0.3503 on 02/02/24 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 1.1000 on 05/24/24 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 94,919 | 316,695,392 | 202,015,744 | 187,838,960 | 123,532,512 |
| Shares Outstanding, K | 93,058 | 1,550,908 | 539,068 | 1,240,680 | 2,036,474 |
| Annual Sales | 100,000,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -21,170,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 13,640,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -14,680,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.51 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 04/19/24 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 04/19/24 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.76 | 17.19 | 18.54 | 9.80 |